C
CTABF
vs
002001
C
CTABF
002001
Over the past 12 months, CTABF has underperformed Zhejiang Nhu Co Ltd, delivering a return of 0% compared to the Zhejiang Nhu Co Ltd's +61% growth.
This Feature is Available on
Paid Plans
Paid Plans
This Feature is Available on Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
14-day money-back guarantee
Smart Verdict
AI-Powered
Not Sure Which Stock Wins?
Let AI Decide.
Let AI Decide.
CTABF
002001
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Summarizing...
We need a little more time to summarize the results
Valuation Comparison
C
CTABF
Intrinsic Value
Not Available
Intrinsic Value
33.72
CNY
Overvaluation 5%
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
C
|
Canntab Therapeutics Ltd
OTC:CTABF
|
0.0001
USD
|
|||||
|
Zhejiang Nhu Co Ltd
SZSE:002001
|
35.43
CNY
|
|||||
No Stocks Selected
Compare the stock's valuation with its competitors.
Valuation Scenario:
Growth Comparison
Growth Over Time
CTABF, 002001
CTABF, 002001
Revenue
www.alphaspread.com
No Stocks Selected
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
C
|
Canntab Therapeutics Ltd
Revenue
|
|||||||||||
|
|
Zhejiang Nhu Co Ltd
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
No Stocks Selected
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
CTABF, 002001
CTABF, 002001
Free Cash Flow
www.alphaspread.com
No Stocks Selected
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
C
|
Canntab Therapeutics Ltd
OTC:CTABF
|
|||||||||
|
|
Zhejiang Nhu Co Ltd
SZSE:002001
|
|||||||||
No Stocks Selected
Compare company's free cash flow with its competitors.
Gross Margin
CTABF
-43.9%
Zhejiang Nhu Co Ltd
44.9%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
Canntab Therapeutics Ltd | ||||
|
|
Zhejiang Nhu Co Ltd | ||||
Operating Margin
CTABF
-2 967.9%
Zhejiang Nhu Co Ltd
37.2%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
Canntab Therapeutics Ltd | ||||
|
|
Zhejiang Nhu Co Ltd | ||||
Net Margin
CTABF
-4 565.3%
Zhejiang Nhu Co Ltd
32%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
Canntab Therapeutics Ltd | ||||
|
|
Zhejiang Nhu Co Ltd | ||||
FCF Margin
CTABF
-1 945%
Zhejiang Nhu Co Ltd
27.5%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
Canntab Therapeutics Ltd | ||||
|
|
Zhejiang Nhu Co Ltd | ||||
ROE
CTABF
607.8%
Zhejiang Nhu Co Ltd
24.1%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
Canntab Therapeutics Ltd | ||||
|
|
Zhejiang Nhu Co Ltd | ||||
ROA
CTABF
-107.5%
Zhejiang Nhu Co Ltd
16.6%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
Canntab Therapeutics Ltd | ||||
|
|
Zhejiang Nhu Co Ltd | ||||
ROIC
CTABF
-102.1%
Zhejiang Nhu Co Ltd
21.7%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
Canntab Therapeutics Ltd | ||||
|
|
Zhejiang Nhu Co Ltd | ||||
ROCE
CTABF
-1 188.4%
Zhejiang Nhu Co Ltd
23%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
Canntab Therapeutics Ltd | ||||
|
|
Zhejiang Nhu Co Ltd | ||||
Solvency Comparison
No Stocks Selected
Compare company's equity waterfall with its competitors.
Balance Sheet Comparison
Stocks Performance
Stocks Performance
CTABF, 002001
CTABF, 002001
Performance Gap
CTABF, 002001
CTABF, 002001
Performance By Year
CTABF, 002001
CTABF, 002001
Loading
No Stocks Selected
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Compare CTABF to other stocks
SUNPHARMA
Sun Pharmaceutical Industries...
Cheaper
vs CTABF
SDZ
Sandoz Group AG
S
Cheaper
vs CTABF
DD
Dupont De Nemours Inc
Cheaper
vs CTABF
300765
CSPC Innovation Pharmaceutical...
C
Cheaper
vs CTABF
Select Stock to Compare
| IN |
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
|
| CH |
S
|
Sandoz Group AG
SIX:SDZ
|
|
| US |
|
Dupont De Nemours Inc
NYSE:DD
|
|
| CN |
|
Zhejiang Nhu Co Ltd
SZSE:002001
|
|
| CN |
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
|
| CN |
|
Hebei Changshan Biochemical Pharmaceutical Co Ltd
SZSE:300255
|
|
| US |
|
Balchem Corp
NASDAQ:BCPC
|
|
| CN |
C
|
Changchun High & New Technology Industries Group Inc
SZSE:000661
|
|
| UK |
|
Croda International PLC
LSE:CRDA
|
|
| ES |
|
Laboratorios Farmaceuticos ROVI SA
MAD:ROVI
|
Loading...
Unlock Full Access to Alpha Spread
Create Free Account
